Want to see DE:MAK full AI Analyst Report?

MATERNUS-Kliniken AG (MAK) Price & Analysis

2 Followers

MAK Stock Chart & Stats

€0.98

-€0.01(-0.71%)

At close: Jan 08 4:00 PM EST

€0.98

-€0.01(-0.71%)

Day’s Range― - ―

52-Week Range€0.81 - €10.90

Previous CloseN/A

Volume132.00

Average Volume (3M)618.00

Market Cap

€19.82M

Enterprise Value€199.25M

Total Cash (Recent Filing)€5.35M

Total Debt (Recent Filing)€183.19M

Price to Earnings (P/E)―

Beta0.60

Next Earnings

Aug 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.76

Shares Outstanding20,970,000

10 Day Avg. Volume1,293

30 Day Avg. Volume618

Financial Highlights & Ratios

PEG Ratio-0.32

Price to Book (P/B)-0.27

Price to Sales (P/S)0.18

P/FCF Ratio1.92

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Positive Free Cash FlowConsistent positive operating cash flow and improving free cash flow provide durable internal funding for working capital, maintenance capex and debt servicing. Over months this reduces immediate refinancing pressure and supports operational continuity despite weak equity.

Recurring, Defensive Revenue ModelA business built on long-term residential care yields predictable, contract-like cash inflows and high revenue visibility relative to transactional businesses. This structural demand profile supports steady occupancy and recurring margins over multiple months (subject to pricing and payor mixes).

Narrowing Operating LossesAn improving operating trend indicates management action on costs and operations is taking hold. If maintained, narrowing losses can translate into sustainable margin recovery and better cash conversion over the medium term, improving the path to structural profitability.

Bears Say

Negative Shareholders' EquityA materially negative equity base signals an impaired capital structure and limits financial flexibility. Over months this raises the likelihood of covenant breaches, need for equity injections or restructurings and reduces buffer against shocks or further operating volatility.

High Leverage Vs AssetsDebt exceeding the asset base creates structural refinancing and solvency risk. Interest and principal obligations constrain investment and cash allocation decisions; with modest cash flow coverage, de-leveraging will be slow absent asset sales or capital relief, impairing strategic options.

Sharp Revenue Decline In 2025A sudden one‑year revenue drop of ~33% indicates material volume or pricing weakness that undermines operating leverage. If persistent, this erodes margins and cash generation, making it harder to stabilize profitability and address capital structure weaknesses over the coming months.

MAK FAQ

What was MATERNUS-Kliniken AG’s price range in the past 12 months?

MATERNUS-Kliniken AG lowest stock price was €0.81 and its highest was €10.90 in the past 12 months.

What is MATERNUS-Kliniken AG’s market cap?

MATERNUS-Kliniken AG’s market cap is €19.82M.

When is MATERNUS-Kliniken AG’s upcoming earnings report date?

MATERNUS-Kliniken AG’s upcoming earnings report date is Aug 20, 2026 which is in 50 days.

How were MATERNUS-Kliniken AG’s earnings last quarter?

MATERNUS-Kliniken AG released its earnings results on Apr 30, 2026. The company reported -€0.563 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.563.

Is MATERNUS-Kliniken AG overvalued?

According to Wall Street analysts MATERNUS-Kliniken AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MATERNUS-Kliniken AG pay dividends?

MATERNUS-Kliniken AG does not currently pay dividends.

What is MATERNUS-Kliniken AG’s EPS estimate?

MATERNUS-Kliniken AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MATERNUS-Kliniken AG have?

MATERNUS-Kliniken AG has 20,970,000 shares outstanding.

What happened to MATERNUS-Kliniken AG’s price movement after its last earnings report?

MATERNUS-Kliniken AG reported an EPS of -€0.563 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8%.

Which hedge fund is a major shareholder of MATERNUS-Kliniken AG?

Currently, no hedge funds are holding shares in DE:MAK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MATERNUS-Kliniken AG Stock Smart Score

Underperform

Technicals

Top Smart Score Stocks >

Company Description

MATERNUS-Kliniken AG

Maternus-Kliniken AG oversees a network of facilities that includes retirement and nursing residences, rehabilitation centers, and a variety of specialized service companies. This enterprise primarily focuses on delivering geriatric care and medical rehabilitation services. Furthermore, it offers an extensive range of support options, such as emergency response systems, assisted living arrangements, and various care modalities including home care, residential care, temporary stays, and care for individuals with disabilities. Its services also encompass comprehensive rehabilitation and post-treatment programs. The company maintains roughly 23 establishments throughout Germany. Founded in 1877, Maternus-Kliniken AG's corporate headquarters are situated in Berlin, Germany.